Minutes of meeting: September 24-25, 1998.
D026683:Advisory Committees; D003219:Confidentiality; D005314:Embryonic and Fetal Development; D005315:Fetal Diseases / Q000628:therapy*; D033042:Fetal Research; D005817:Genetic Counseling; D030342:Genetic Diseases, Inborn; D015316:Genetic Therapy; D006805:Human Experimentation; D006801:Humans; D007153:Immunologic Deficiency Syndromes; D007258:Informed Consent; D033282:Parental Consent; D018579:Patient Selection; D011247:Pregnancy; D037841:Pregnant People; D011640:Public Policy; D012106:Research; D012107:Research Design; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D013789:Thalassemia; D020458:Third-Party Consent; D014481:United States
Biomedical and Behavioral Research; Genetics and Reproduction; Recombinant DNA Advisory Committee